Found: 7
Select item for more details and to access through your institution.
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 4, p. 497, doi. 10.1007/s00428-023-03640-4
- By:
- Publication type:
- Article
Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 2, p. 281, doi. 10.1007/s00428-021-03217-z
- By:
- Publication type:
- Article
A comprehensive analysis of the expression, epigenetic and genetic changes of HNF1B and ECI2 in 122 cases of high-grade serous ovarian carcinoma.
- Published in:
- Oncology Letters, 2021, v. 21, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12446
- By:
- Publication type:
- Article
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
- Published in:
- Diagnostic Pathology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13000-023-01358-0
- By:
- Publication type:
- Article
Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74059-z
- By:
- Publication type:
- Article
HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71427-7
- By:
- Publication type:
- Article
Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal Lesions: an Analysis of 145 Cases.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2337, doi. 10.1007/s12253-020-00830-2
- By:
- Publication type:
- Article